Drug Shortage Report for RIVA-OXYBUTYNIN
Report ID | 26906 |
Drug Identification Number | 02299364 |
Brand name | RIVA-OXYBUTYNIN |
Common or Proper name | Oxybutynin 5mg |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | OXYBUTYNIN CHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 & 500 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-10-31 |
Actual start date | 2017-11-08 |
Estimated end date | 2018-04-20 |
Actual end date | 2018-04-20 |
Shortage status | Resolved |
Updated date | 2018-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2018-05-02 | French | Compare |
v12 | 2018-05-02 | English | Compare |
v11 | 2018-03-30 | French | Compare |
v10 | 2018-03-30 | English | Compare |
v9 | 2018-02-23 | French | Compare |
v8 | 2018-02-23 | English | Compare |
v7 | 2017-12-18 | French | Compare |
v6 | 2017-12-18 | English | Compare |
v5 | 2017-11-13 | French | Compare |
v4 | 2017-11-13 | English | Compare |
v3 | 2017-11-01 | English | Compare |
v2 | 2017-10-24 | French | Compare |
v1 | 2017-10-24 | English | Compare |
Showing 1 to 13 of 13